A drug that, when taken daily, could greatly reduce the chances of becoming infected with HIV has been submitted to Health Canada for approval.
PrEP has been a controversial method in both medical and LGBT communities, so we asked two experts to break it down for us.
Dr. Ann Stewart is the medical director at Casey House, an HIV/AIDS hospital in Toronto and Sean Hosein is the Science and Medicine Editor at CATIE.